TUDCA for Retinal Degeneration: What Photoreceptor Research Currently Shows
A review of preclinical evidence on TUDCA and photoreceptor protection in retinal degeneration, including proposed mechanisms and animal model findings.
A review of preclinical evidence on TUDCA and photoreceptor protection in retinal degeneration, including proposed mechanisms and animal model findings.
A plain-language review of the preclinical evidence for TUDCA in Parkinson’s disease, covering dopamine neuron protection, mitochondria, and research limits.
An evidence-based look at how TUDCA may influence ER stress, insulin sensitivity, and fat cell biology in obesity and metabolic syndrome research.
An evidence-based look at how TUDCA may protect neurons, the mechanisms proposed by researchers, and where human evidence stands today.
A science-based look at how TUDCA may affect NAFLD and NASH through bile acid regulation, ER stress, and gut-liver axis mechanisms.
TUDCA blocks Bax-driven cytochrome c release and Bad activation to inhibit mitochondrial apoptosis. Here is what the research shows.
An honest look at TUDCA’s liver-protective mechanisms, what animal and early human research shows, and important safety considerations.
TUDCA may support insulin sensitivity by reducing endoplasmic reticulum stress in metabolic tissues. Here’s what animal studies and early research reveal.
What do animal studies show about TUDCA’s neuroprotective potential in Huntington’s disease? An honest summary of the preclinical evidence and its limits.
TUDCA is known for liver protection, but growing research explores its effects on gut barrier function and the microbiome.
A plain-language look at how TUDCA interacts with endoplasmic reticulum stress and the unfolded protein response, with citations to current research.
TUDCA is clinically studied for cholestasis, including primary biliary cholangitis and ICP. Review the evidence, mechanisms, and honest limitations.